BioStem Technologies, Inc. (OTC: BSEM) reported Q1 EPS of $0.27, $0.24 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $72.53 million versus the consensus estimate of $82.5 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.